CollPlant Biotechnologies (CLGN) Total Debt (2017 - 2021)

CollPlant Biotechnologies has reported Total Debt for 5 years, with the latest figure at $5.7 million in Q3 2021.

• For the quarter ending Q3 2021, Total Debt rose 454.95% year-over-year to $5.7 million; the trailing twelve-month figure through Sep 2021 stood at $5.7 million (up 454.95% YoY), and the FY2020 full-year result was -$3.3 million, up 43.86% from the prior year.
• Total Debt for Q3 2021 stood at $5.7 million, down from $8.2 million in the prior quarter.
• The five-year high for Total Debt was $17.8 million in Q1 2018, with the low at -$5.9 million in Q4 2019.
• Historically, Total Debt has averaged $1.4 million across 5 years, with a median of -$1.5 million in 2020.
• Annual changes were most pronounced in 2018 — Total Debt plunged 164.86% — and 2021, when it surged 864.04%.
• CollPlant Biotechnologies' Total Debt stood at $3.6 million in 2017, then sank by 164.86% to -$2.4 million in 2018, then tumbled by 150.68% to -$5.9 million in 2019, then soared by 43.86% to -$3.3 million in 2020, then surged by 271.24% to $5.7 million in 2021.
• The last three Total Debt figures came in at $5.7 million (Q3 2021), $8.2 million (Q2 2021), and $10.6 million (Q1 2021), per Business Quant data.